Anti-corruption and FCPA enforcement affect more companies in Asia than ever before. FCPA compliance is especially challenging in China, where government regulation of the economy remains rigorous and state-owned enterprises continue to dominate many sectors. Several published cases in recent years Siemens, Faro Technologies, AGA Medical, Lucent, Schnitzer Steel, ITT, York International, Diagnostic Products (to name a few) have focused on activities in China. Many more pending investigations reportedly involve compliance issues in China.
If your company is doing business in China, you must have a comprehensive and updated anti-bribery and FCPA compliance program and be prepared to act promptly and effectively to remedy any problem that do arise. American Conference Institute 3rd China Forum will once again provide insightful information on:
- The anti-corruption and FCPA regulatory and enforcement landscape in China
- Conducting corruption risk assessments and internal investigations
- Risk-oriented due diligence process for intermediaries and joint-venture partners in China
- Core components of an effective anti-corruption compliance program for Chinese operations
